P186 Airway clearance in the STOP PEDS pilot study of oral antibiotic treatment strategies for paediatric cystic fibrosis pulmonary exacerbations

Increased frequency of airway clearance therapy (ACT) is a key component of pulmonary exacerbation (PEx) treatment. STOP PEDS (Streamlined Treatment of Pulmonary exacerbations in Pediatrics) was a multicenter, prospective, open-label feasibility study in which oral antibiotic treatment for a mild outpatient pulmonary exacerbation was assigned randomly to either “immediate oral antibiotics” or “tailored therapy” (oral antibiotics started only for pre-specified criteria). Here we report the self-reported frequency of ACT among participants in both arms.